Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with glutamate receptor antagonists MK-801 and CPP

Journal of Neuroscience

Volumn 16, Issue 16, 1996, Pages 5216-5224

  Emmi, Adriana ^a   Rajabi, Heshmat ^a   Stewart, Jane ^a  

^a and Applied Physiology   (Canada)

Author keywords

6 OHDA lesions; behavioral recovery; CPP; glutamate; microdialysis; MK 801; NMDA antagonists; striatal dopamine; substantia nigra

Indexed keywords

4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; DIZOCILPINE; DOPAMINE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; OXIDOPAMINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BINDING COMPETITION; BRAIN INJURY; CONTROLLED STUDY; DOPAMINE RELEASE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SUBSTANTIA NIGRA;

EID: 0029738633     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-16-05216.1996     Document Type: Article

References (45)

1. Abercrombie ED, Bonatz AE, Zigmond MJ (1990) Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res 525:36-44.
2. Akimoto K, Hamamura T, Kazahaya Y, Akiyama K, Otsuki S (1990) Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine - an in vivo dialysis study in freely moving rats. Brain Res 507:344-346.
3. Albin R, Young A, Penney J (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
4. Bambrick L, Yarowsky P, Krueger B (1995) Glutamate as a hippocampal neuron survival factor: an inherited defect in the trisomy 16 mouse. Proc Natl Acad Sci USA 92:9692-9696.
5. Carter CJ (1982) Topographical distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats. Neuropharmacol 21:379-383.
6. Castañeda E, Whishaw IQ, Robinson TE (1990) Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J Neurosci 10:1847-1854.
7. Fitzgerald LW, Deutch AY, Gasic G, Heinemann F, Nestler EJ (1995) Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J Neurosci 15:2453-2461.
8. Gauchy C, Desban M, Glowinski J, Kernel ML (1994) NMDA regulation of dopamine release from proximal and distal dendrites in the cat substantia nigra. Brain Res 635:249-256.
9. Greenamyre J, O'Brien C (1991) N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease. Arch Neurol 48:977-981.
10. Hollerman J, Grace A (1992) Subthalamic nucleus cell firing in the 6-OHDA-treated rat: basal activity and response to haloperidol. Brain Res 590:291-299.
11. Kalivas PW (1995) Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend 37:95-100.
12. Kalivas PW, Alesdatter JE (1993) Involvement of NMDA receptor stimulation in the VTA and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267:486-495.
13. Kalivas PW, Duffy P (1993) Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13:266-275.
14. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244.
15. Kalivas PW, Weber B (1988) Amphetamine injection into the A10 dopamine region sensitizes rats to peripheral amphetamine and cocaine. J Pharmacol Exp Ther 245:1095-1102.
16. Karler R, Calder LD, Chaudhry IA, Turkanis SA (1989) Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci 45:599-606.
17. Karler R, Chaudhry IA, Calder LD, Turkanis SA (1990) Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res 537:76-82.
18. Karreman M, Moghaddam B (1996) The prefrontal cortex controls the basal release of DA in the medial striatum: an effect mediated by dopamine cell bodies. J Neurochem 66:589-598.
19. Keefe KA, Zigmond MJ, Abercrombie ED (1992) Extracellular dopamine in striatum influence nerve impulse activity in medial forebrain bundle and local glutamatergic input. Neuroscience 47:325-332.
20. Keefe K, Sved A, Zigmond M, Abercrombie E (1993) Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous amino acids. J Neurochem 61:1943-1952.
21. Kolta MG, Shreve P, De Souza V, Uretsky NJ (1985) Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology 24:823-829.
22. Kornhuber J, Kim J, Kornhuber M, Kornhuber H (1984) The corticonigral projection: reduced glutamate content in the substantia nigra following frontal cortex ablation in the rat. Brain Res 322:124-126.
23. Moghaddam B, Bunney B (1993) Depolarization inactivation of dopamine neurons: terminal release characteristics. Synapse 14:195-200.
24. Overton P, Clark D (1992) Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat. Synapse 10:131-140.
25. Patrick SL, Thompson TL, Walker JM, Patrick RL (1991) Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus. Brain Res 538:343-346.
26. Patterson T, Schenk J (1991) Effects of acute and chronic systemic administration of some typical antipsychotic drugs on turnover of dopamine and potassium ion-induced release of dopamine in the striatum of the rat in vivo. Neuropharmacology 30:943-952.
27. Paulson PE, Robinson TE (1995) Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19:56-65.
28. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 396:157-198.
29. Robinson TE, Whishaw IQ (1988) Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res 450:209-224.
30. Robinson TE, Jurson PA, Bennett JA, Bentgen KM (1988) Persistent sensitization of dopamine neurotransmission in ventral striatum nucleus accumbens produced by prior experience with +-amphetamine: a microdialysis study in freely moving rats. Brain Res 462:211-222.
31. Robinson TE, Mocsary Z, Camp DM, Whishaw IQ (1994) Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J Neurosci 14:2687-2696.
32. Smith I, Grace A (1992) Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse 12:287-303.
33. Snyder G, Keller RWJ, Zigmond MJ (1990) Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. J Pharmacol Exp Ther 253:867-876.
34. Steiner H, Bonatz AE, Huston JP, Schwarting R (1988) Lateralizad wall-facing versus turning as measures of behavioral asymmetries and recovery function after injection of 6-hydroxydopamine into the substantia nigra. Exp Neurol 99:556-566.
35. Stewart J, Druhan JP (1993) Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology 110:125-132.
36. Taber M, Das S, Fibiger H (1995) Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area. J Neurochem 65:1407-1410.
37. Vezina P (1993) Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res 605:332-337.
38. Vezina P (1996) D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area, J Neurosci 16:2411-2420.
39. Vezina P, Stewart J (1990) Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res 516:99-106.
40. Wolf ME Jeziorski M (1993) Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res 613:291-294.
41. Wolf ME, Khansa MR (1991) Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562:164-168.
42. Wolf ME, White FJ, Hu X (1994) MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J Neurosci 14:1735-1745.
43. Woolley C, McEwen B (1994) Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci 14:7680-7687.
44. Yamamoto B, Cooperman M (1994) Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J Neurosci 14:4159-4166.
45. Zigmond MJ, Hastings TG, Abercrombie ED (1992) Neurochemical responses to 6-hydroxydopamine and L-DOPA therapy: implication for Parkinson's disease. Ann N Y Acad Sci 648:71-86.